Microbiota Evaluation of Patients With a Boston Type I Keratoprosthesis Treated With Topical 0.5% Moxifloxacin and 5% Povidone-Iodine

Magalhaes, Fernanda Pedreira [UNIFESP]; Nascimento, Heloisa Moraes do [UNIFESP]; Ecker, David J.; Sannes-Lowery, Kristin A.; Sampath, Rangarajan; Rosenblatt, Mark I.; Sousa, Luciene Barbosa de [UNIFESP]; Oliveira, Lauro Augusto de [UNIFESP]

Microbiota Evaluation of Patients With a Boston Type I Keratoprosthesis Treated With Topical 0.5% Moxifloxacin and 5% Povidone-Iodine

Data

2013-04-01

Autores

Magalhaes, Fernanda Pedreira [UNIFESP]

Nascimento, Heloisa Moraes do [UNIFESP]

Ecker, David J.

Sannes-Lowery, Kristin A.

Sampath, Rangarajan

Rosenblatt, Mark I.

Sousa, Luciene Barbosa de [UNIFESP]

Oliveira, Lauro Augusto de [UNIFESP]

Tipo

Artigo

Resumo

Purpose: To evaluate the efficacy of a prophylactic regimen of daily topical 0.5% moxifloxacin and 5% povidone-iodine (PI) in patients with Boston type I keratoprosthesis (KPro) and to assess the applicability of a novel molecular diagnostic technique to analyze the ocular surface microbiota in these patients.Methods: Ten patients had their inferior conjunctival fornix sampled for standard culture methods before the addition of topical 5% PI to the prophylactic regimen and were considered the control group (group 1). the inferior conjunctival fornix and the KPro-donor cornea interface of 10 patients treated with the mentioned prophylactic regimen were sampled and analyzed by standard culture methods and using a polymerase chain reaction/electrospray ionization mass spectrometry assay (group 2).Results: Samples from the inferior conjunctival fornix were positive for coagulase-negative staphylococcus in 3 patients and for Aerobasidium pullulans in 1 patient in group 1. the inferior conjunctival fornix and the KPro-donor cornea interface scrapings were positive for coagulase-negative staphylococcus in 2 patients and 1 patient, respectively, in group 2. No bacteria and fungi growth were detected in any patient from group 2 with the molecular diagnostic approach. None of the patients with culture-positive results developed keratitis or endophthalmitis during the study.Conclusions: Topical 0.5% moxifloxacin associated with topical 5% PI is an effective prophylactic regimen in patients with Boston type I KPro. the molecular diagnostic approach using serial polymerase chain reaction and mass spectrometry was comparable with standard microbiologic techniques as a surveillance tool in these patients.

Citação

Cornea. Philadelphia: Lippincott Williams & Wilkins, v. 32, n. 4, p. 407-411, 2013.